FindTrial
Sign In

Oral Insulin

DRUG8 trials

Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Profil Institut für Stoffwechselforschung GmbH, Technical University of Munich, Oramed, Ltd., Roger New

Conditions

Diabetes Mellitus, Type 1Non-Alcoholic Steatohepatitis (NASH)Stage 1 Diabetes Mellitus, Type 1Type 2 DiabetesType 2 Diabetes Treated With InsulinType2 Diabetes Mellitus

Phase 1

Oral Insulin: A Comparison With Subcutaneous Regular Human Insulin in Patients With Type 2 Diabetes
CompletedNCT00982254
Profil Institut für Stoffwechselforschung GmbHType 2 Diabetes
Start: 2001-10-31Updated: 2009-09-23

Phase 2

Pre-POINT-Early Study
CompletedNCT02547519
Technical University of MunichDiabetes Mellitus, Type 1
Start: 2015-08-31End: 2017-12-31Updated: 2018-02-13
Fr1da Insulin Intervention
CompletedNCT02620072
Technical University of MunichStage 1 Diabetes Mellitus, Type 1
Start: 2015-12-11End: 2024-09-30Updated: 2024-10-08
A Pilot Study to Assess the Safety of Oral Insulin in Patients With Nonalcolholic Steatohepatitis (NASH)
CompletedNCT02653300
Oramed, Ltd.Non-Alcoholic Steatohepatitis (NASH), Type2 Diabetes Mellitus
Start: 2018-09-20End: 2020-04-01Updated: 2024-03-13
GPPAD-POInT (Global Platform of Autoimmune Diabetes - Primary Oral Insulin Trial)
CompletedNCT03364868
Technical University of MunichDiabetes Mellitus, Type 1
Start: 2018-02-07End: 2024-06-28Updated: 2024-10-08
Study to Evaluate the Safety and Efficacy of Oral Insulin Formulation in Type 2 Diabetes Mellitus Subjects
CompletedNCT06473662
Roger NewType 2 Diabetes Treated With Insulin
Start: 2018-10-22End: 2020-07-11Updated: 2025-02-06

Phase 3

The Diabetes Prevention Trial of Type 1 Diabetes (DPT-1)
CompletedNCT00004984
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Diabetes Mellitus, Type 1
Start: 1994-02-28End: 2003-06-30Updated: 2020-04-24
Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus
CompletedNCT00419562
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Diabetes Mellitus, Type 1
Start: 2007-02-28End: 2017-06-30Updated: 2020-05-07

Related Papers

Efficacy of once-daily, high-dose, oral insulin immunotherapy in children genetically at risk for type 1 diabetes (POInT): a European, randomised, placebo-controlled, primary prevention trial.
2025-11-11
From cause to consequence: Insights into incident diabetes mellitus after hepatic steatosis
Clinical Liver Disease2023-01-132 citations
Oral insulin immunotherapy in children at risk for type 1 diabetes in a randomised controlled trial
Diabetologia2021-01-2955 citations
Interferon β-1a (IFNβ-1a) in COVID-19 patients (INTERCOP): study protocol for a randomized controlled trial.
2020-11-2321 citations
Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk: the GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol
BMJ Open2019-06-0187 citations
Effect of Oral Insulin on Prevention of Diabetes in Relatives of Patients With Type 1 Diabetes
JAMA2017-11-21198 citations
How many unpublished studies? ClinicalTrials.gov (n = 2614 studies): diabetes | Closed Studies | Interventional Studies | Phase 3, 4 | Search Date: Oct 27, 2014
Figshare2014-01-01